Phase 1 trial results demonstrate that psilocybin in conjunction with psychological support is safe, tolerable and deemed acceptable and therapeutically meaningful by female individuals with anorexia nervosa.
- Stephanie Knatz Peck
- Samantha Shao
- Walter H. Kaye